Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection.
Eighteen patients are reported who have had a regional pancreatectomy. The pancreatic segment of portal vein was excised with en bloc total pancreatectomy and regional lymph node dissection in all 18. Venous repair was by end-to-end anastomosis without a graft. Five of the 18 also had various arterial resections and reconstructions. Sixteen of the 18 had been explored and deemed nonresectable elsewhere. This operation has doubled the resectability rate in this institution. The 30-day operative mortality rate was 16.6%. Acurarial survival is 62% at one year compared with 36% one year survival rate for patients undergoing pancreaticoduodenectomy for less advanced cancer in previous years. A more valid comparison would be between those who had a palliative procedure since most patients in the present series were initially considered unresectable. One year survival for these patients was 22%. The quality of life was good for most patients.
D000230:Adenocarcinoma / Q000601:surgery; D007516:Adenoma, Islet Cell / Q000601:surgery; D000328:Adult; D000368:Aged; D001650:Bile Duct Neoplasms / Q000601:surgery; D004379:Duodenal Neoplasms / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006499:Hepatic Artery / Q000601:surgery; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D008638:Mesenteric Arteries / Q000601:surgery; D008875:Middle Aged; D010180:Pancreatectomy / Q000379:methods* / Q000401:mortality; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000601:surgery*; D011169:Portal Vein / Q000601:surgery*; D011183:Postoperative Complications